regeneron glp-1 gip treatment muscle loss side effects Emerging Role of Myostatin Inhibitors in the Management of Glucagon-Like Peptide-1-Associated Sarcopenia and Metabolic Disorders The GLP-1 race may have

That panel includes fasting glucose, insulin, HOMA-IR, a lipid panel, liver and kidney function, and hormonal evaluation for menstruating individuals

More serious but rare adverse effects include pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), and acute kidney injury, which require prompt medical evaluation if symptoms develop

For Prescribers: Partner With a Pharmacy That Earns Your Trust If you are managing patients on GLP-1 therapy, whether initiating treatment, managing side effects through individualized titration, or supporting long-term metabolic goals, you deserve a compounding partner with the precision, safety, and flexibility only an accredited sterile compounder can provide

Last reviewed: July 3, 2026 Last updated: July 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations